In a cohort of 514 consecutively resected gastric cancers, the subset of EBV-positive GaC cases (n = 32; 6.2%) showed higher PD-L1 expression (overall, in tumor cells, and immune cells) and worse prognosis compared to conventional, EBV-negative GaC cases. This evidence concerns the gene CD274 and neoplasm.